Robust growth of avirulent phase II Coxiella burnetii in bone marrow-derived murine macrophages
Open Access
- 9 March 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (3) , e0173528
Abstract
Published data show that murine bone marrow-derived macrophages (BMDM) restrict growth of avirulent phase II, but not virulent phase I, Coxiella burnetii. Growth restriction of phase II bacteria is thought to result from potentiated recognition of pathogen-associated molecular patterns, which leads to production of inhibitory effector molecules. Past studies have used conditioned medium from L-929 murine fibroblasts as a source of macrophage-colony stimulating factor (M-CSF) to promote differentiation of bone marrow-derived myeloid precursors into macrophages. However, uncharacterized components of conditioned medium, such as variable amounts of type I interferons, can affect macrophage activation status and their permissiveness for infection. In the current study, we show that the C. burnetii Nine Mile phase II (NMII) strain grows robustly in primary macrophages from C57BL/6J mice when bone marrow cells are differentiated with recombinant murine M-CSF (rmM-CSF). Bacteria were readily internalized by BMDM, and replicated within degradative, LAMP1-positive vacuoles to achieve roughly 3 logs of growth over 6 days. Uninfected BMDM did not appreciably express CD38 or Egr2, markers of classically (M1) and alternatively (M2) activated macrophages, respectively, nor did infection change the lack of polarization. In accordance with an M0 phenotype, infected BMDM produced moderate amounts of TNF and nitric oxide. Similar NMII growth results were obtained using C57BL/6J myeloid progenitors immortalized with an estrogen-regulated Hoxb8 (ER-Hoxb8) oncogene. To demonstrate the utility of the ER-Hoxb8 system, myeloid progenitors from natural resistance-associated macrophage protein 1 (Nramp1) C57BL/6J knock-in mice were transduced with ER-Hoxb8, and macrophages were derived from immortalized progenitors using rmM-CSF and infected with NMII. No difference in growth was observed when compared to macrophages from wild type mice, indicating depletion of metal ions by the Nramp1 transporter does not negatively impact NMII growth. Results with NMII were recapitulated in primary macrophages where C57BL/6J Nramp1+ BMDM efficiently killed Salmonella enterica serovar Typhimurium. M-CSF differentiated murine macrophages from bone marrow and conditional ER-Hoxb8 myeloid progenitors will be useful ex vivo models for studying Coxiella-macrophage interactions.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (1 Z1A AI00931)
This publication has 67 references indexed in Scilit:
- Dot/Icm Type IVB Secretion System Requirements for Coxiella burnetii Growth in Human MacrophagesmBio, 2011
- Isolation from Animal Tissue and Genetic Transformation of Coxiella burnetii Are Facilitated by an Improved Axenic Growth MediumApplied and Environmental Microbiology, 2011
- A unique Coxiella burnetii lipoprotein involved in metal binding (LimB)Microbiology, 2011
- Inhibition of pathogen-induced apoptosis by a Coxiella burnetii type IV effector proteinProceedings of the National Academy of Sciences, 2010
- Coxiella burnetii Phase I and II Variants Replicate with Similar Kinetics in Degradative Phagolysosome-Like Compartments of Human MacrophagesInfection and Immunity, 2010
- Bacterial manipulation of innate immunity to promote infectionNature Reviews Microbiology, 2010
- Comparative Genomics Reveal Extensive Transposon-Mediated Genomic Plasticity and Diversity among Potential Effector Proteins within the GenusCoxiellaInfection and Immunity, 2009
- Adaptive immunity to the obligate intracellular pathogen Coxiella burnetiiImmunologic Research, 2008
- Limited Role for Iron Regulation in Coxiella burnetii PathogenesisInfection and Immunity, 2008
- AttenuatedCoxiella burnetiiPhase II Causes a Febrile Response in Gamma Interferon Knockout and Toll-Like Receptor 2 Knockout Mice and Protects against ReinfectionInfection and Immunity, 2007